| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $49.81 ▲ +0.77% | Yesterday | $49.43 • 0.00% | Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.43 and targets $49.81 (+0.77%). The near-term read is upside; watch $51.80 / $47.06 because daily realized volatility is about 6.35%. |
Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.43 and targets $49.81 (+0.77%). The near-term read is upside; watch $51.80 / $47.06 because daily realized volatility is about 6.35%. | ||||
| Week | $51.21 ▲ +3.60% | Last Week | $49.43 • 0.00% | The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $49.43 to $51.21 (+3.60%). It gives upside momentum context for this stock, so breaks around $51.80 / $47.06 matter more than a single tick. |
The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $49.43 to $51.21 (+3.60%). It gives upside momentum context for this stock, so breaks around $51.80 / $47.06 matter more than a single tick. | ||||
| Month | $53.47 ▲ +8.17% | Last Month | $49.43 • 0.00% | The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.47 (+8.17%), compared with the live reference near $49.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.47 (+8.17%), compared with the live reference near $49.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $56.77 ▲ +14.85% | Last Year | $49.43 • 0.00% | The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $56.77 (+14.85%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $56.77 (+14.85%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $64.44 ▲ +30.37% | 5 Years Ago | $49.43 • 0.00% | The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $64.44 (+30.37%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $64.44 (+30.37%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 50.1 | Neutral |
| MACD | 0.02 | Neutral |
| SMA 50 | $50.46 | Below |
| SMA 200 | $50.12 | Below |
| EMA 20 | $50.57 | Below |
| Opening Price | $49.43 | Start Date | 2021-05-17 |
| Day Range | $47.39 – $51.47 | Market Cap | $2.82B |
| Monthly Range | $45.66 – $57.55 | 24h Volume | n/a |
| 90D Range | $44.41 – $58.91 | Circulating | n/a |
| 52W Range | $42.83 – $64.34 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.